Related Experiment Video
Updated: May 28, 2025

Molecular Profiling of the Invasive Tumor Microenvironment in a 3-Dimensional Model of Colorectal Cancer Cells and Ex vivo Fibroblasts
Published on: April 29, 2014
miR-124-3p inhibits CRC proliferation, migration, and invasion by targeting ITGB1
1Pediatrics Department, Northeast International Hospital, Shenyang, 110623, China. wojiushilj3278@126.com.
Abstract:
Colorectal cancer (CRC) was the third most common cause of mortality associated with cancer globally. miR-124-3p has been widely acknowledged for its pivotal role as a tumor suppressor in various malignancies. In this study, we aimed to investigate the specific functions and underlying mechanisms of miR-124-3p in CRC cell proliferation, migration and invasion. A comprehensive set of assays, including CCK-8, colony formation, wound healing assays, flow cytometry, RT-qPCR and Western blotting, were conducted to assess the impact of miR-124-3p expression on CRC cell growth. Our investigations into miR-124-3p and its potential target gene ITGB1 were facilitated through bioinformatics analysis and dual-luciferase reporter assays. To further solidify our findings, rescue experiments were executed to validate the role of miR-124-3p in regulating the proliferation, migration, and apoptosis of CRC cells, genes involving Wnt/β-catenin signaling pathway were also detected. Our study revealed that the overexpression of miR-124-3p significantly suppressed both the proliferation and migratory capabilities of CRC cells, while its downregulation had the opposite effect. Notably, ITGB1 was identified as a putative target gene of miR-124-3p, exhibiting an inverse correlation with the expression levels of miR-124-3p. Moreover, the overexpression of ITGB1 was able to abrogate the inhibitory effects exerted by miR-124-3p overexpression on CRC cell proliferation, migration, and Wnt1/β-catenin protein levels. Our results reveal that miR-124-3p targets ITGB1 to regulate CRC cell proliferation and migration may be associated with the Wnt/β-catenin signaling pathway. These findings provide that a miR-124-3p/ITGB1 axis may be a potential target for the treatment of CRC.
Insights
MicroRNA-124-3p (miR-124-3p) suppresses colorectal cancer (CRC) growth by targeting ITGB1 and inhibiting the Wnt/β-catenin pathway. This miR-124-3p/ITGB1 axis presents a potential therapeutic target for CRC treatment.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Colorectal cancer (CRC) is a leading cause of cancer mortality worldwide.
- MicroRNA-124-3p (miR-124-3p) is recognized as a tumor suppressor in various cancers.
- Understanding miR-124-3p's role in CRC is crucial for developing new therapeutic strategies.
Purpose of the Study:
- To investigate the specific functions and molecular mechanisms of miR-124-3p in colorectal cancer cell proliferation, migration, and invasion.
- To identify potential target genes of miR-124-3p in CRC.
- To explore the involvement of the Wnt/β-catenin signaling pathway.
Main Methods:
- Cell proliferation and apoptosis assays (CCK-8, colony formation, flow cytometry).
- Migration and invasion assays (wound healing).
- Gene expression analysis (RT-qPCR, Western blotting), bioinformatics analysis, dual-luciferase reporter assays, and rescue experiments.
Main Results:
- Overexpression of miR-124-3p significantly inhibited CRC cell proliferation and migration, while downregulation promoted these processes.
- ITGB1 was identified as a direct target of miR-124-3p, with inverse expression correlation.
- ITGB1 overexpression reversed the inhibitory effects of miR-124-3p on CRC cells and Wnt/β-catenin signaling.
Conclusions:
- miR-124-3p suppresses colorectal cancer progression by targeting ITGB1.
- The miR-124-3p/ITGB1 axis regulates CRC cell proliferation and migration, potentially through the Wnt/β-catenin signaling pathway.
- This axis represents a promising therapeutic target for colorectal cancer treatment.

